BioCentury
ARTICLE | Company News

Isis Pharmaceuticals, Biogen Idec deal

May 11, 2015 7:00 AM UTC

Isis received a $10 million milestone payment from Biogen under a 2013 deal under which the companies are using Isis’ antisense technology to identify and validate targets. The milestone was triggered...